86810-83-5

Usage

Uses

Used in Pharmaceutical Synthesis:
4-(cyclopentylsulfonyl)aniline is used as a key intermediate in the synthesis of pharmaceuticals for its ability to be incorporated into complex molecular structures, contributing to the development of new drugs with potential therapeutic benefits.
Used in Agrochemical Production:
In the agrochemical industry, 4-(cyclopentylsulfonyl)aniline serves as an intermediate in the production of various agrochemicals, helping to create compounds that can protect crops and enhance agricultural productivity.
Used in Dye and Pigment Manufacturing:
4-(cyclopentylsulfonyl)aniline is utilized as an intermediate in the manufacturing of dyes and pigments, where its unique properties contribute to the creation of vibrant and stable colorants for a wide range of applications.
Used in Specialty Chemicals:
4-(cyclopentylsulfonyl)aniline is also used in the production of specialty chemicals, where its specific structural features allow for the development of high-performance materials for various industrial uses.
Used in Medicinal Chemistry and Drug Development:
Due to its unique structure and properties, 4-(cyclopentylsulfonyl)aniline has potential applications in medicinal chemistry and drug development, where it can be used to design and synthesize novel therapeutic agents with improved efficacy and selectivity.

Upstream product

• 1849-36-1 para-nitrobenzenethiol 
• 86810-76-6 Cyclopentyl-(4-nitrophenyl)-sulfon 
• 137-43-9 Cyclopentyl bromide 
• 86810-73-3 Cyclopentyl-(4-nitrophenyl)-sulfid 

Downstream Products

• 1224162-17-7 [4-((1R,2R)-2-benzyloxy-1-methylpropoxy)-5-trifluoromethylpyrimidin-2-yl]-(4-cyclopentanesulphonylphenyl)amine 
• 801315-15-1 diethyl ({[4-(cyclopentylsulfonyl)phenyl]amino}methylidene)propanedioate 

Relevant academic research and scientific papers

4,6-DIAMINONICOTINAMIDE COMPOUND

[Problem] The present invention provides a 4,6-diaminonicotinamide compound which is useful as an active ingredient of a pharmaceutical composition, in particular, a pharmaceutical composition for treating diseases caused by undesirable and/or abnormal cytokine signal transduction. [Means for Solution] The present inventors have extensively studied compounds having a JAK3 inhibitory action, and as a result, they have found that a 4,6-diaminonicotinamide compound which is the compound of the present invention has an excellent JAK3 inhibitory action and is useful as an agent for preventing or treating diseases caused by undesirable and/or abnormal cytokine signal transduction, thereby completing the present invention.

(R)-3-(N,N-DIMETHYLAMINO)PYRROLIDINE DERIVATIVES

(R)-3-(N,N-Dimethyiamino)pyrrolidine derivatives of formula (I), wherein the meaning for Cy1 is as disclosed in the description. These compounds are useful as JAK3 kinase inhibitors

QUINOLINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS

There are provided according to the invention novel compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R19, R20 and R34 are as described in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.

Syntheses of Some Alkyl-, Cycloalkyl-, and Aryl-(4-aminophenyl)-sulfones

Syntheses of (4-aminophenyl)-alkyl, -cycloalkyl and -aryl sulfones 2 were achieved both by alkylation of 4-(acetylamino)-benzenesulfinic acid (7) to the corresponding acetanilides 9 followed by hydrolysis and by oxidation of the appropriate (4-nitrophenyl)-sulfides 11 to (4-nitrophenyl)-sulfones 1 with subsequent Bechamp reduction.